Price To Earnings Ratio 33.75 | Sector PE 69.55 |
PB Ratio 6.56 | Sector PB 8.96 |
EPS 136.38 | Dividend Yield 2.02 |
Today's Volume 364.757 K | 5 Day Avg. Volume 99.557 K |
PEG Ratio 18.15 | Market Cap. ₹ 22,980.00 Cr. |
Pfizer Limited is an Indian pharmaceutical company. The company's field of activity is the production, distribution, trade and export of medicines. The company has its own manufacturing facility in Goa. The company has several independent contract/third party manufacturers in India. Its product portfolio includes vaccines, anti-infective, cardiac, pain, maternal nutrition, gastrointestinal, anti-pregnancy, anti-inflammatory, anti-nutritional and anti-immune vaccines, and respiratory vaccines. The company's vaccine business focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants six weeks of age and older as part of the primary immunisation program, infants, adolescents, adults and the elderly. Its inflammation and immunology portfolio includes two advanced therapies serving patients suffering from chronic immune-related diseases such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.